v3.26.3
SEGMENT INFORMATION - Schedule of Financial Information by Segment (Details) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 26, 2026
Sep. 27, 2025
Sep. 26, 2026
Sep. 27, 2025
Segment Reporting [Line Items]        
Net sales $ 7,856 $ 7,115 $ 22,893 $ 20,645
Interest expense, net (118) (213) (373) (646)
Depreciation and amortization     (769) (750)
Stock-based compensation expense (29) (15) (81) (49)
Income before income taxes 386 345 912 1,042
Operating Segments        
Segment Reporting [Line Items]        
Segment adjusted EBITDA 1,127 1,026 3,350 3,129
Operating Segments | Medline Brand        
Segment Reporting [Line Items]        
Net sales 3,637 3,411 10,642 9,997
Segment adjusted EBITDA 943 821 2,775 2,541
Operating Segments | Supply Chain Solutions        
Segment Reporting [Line Items]        
Net sales 4,219 3,704 12,251 10,648
Segment adjusted EBITDA 184 205 575 588
Operating Segments | Front Line Care | Medline Brand        
Segment Reporting [Line Items]        
Net sales 1,706 1,634 4,976 4,752
Operating Segments | Surgical Solutions | Medline Brand        
Segment Reporting [Line Items]        
Net sales 1,659 1,538 4,853 4,494
Operating Segments | Laboratory and Diagnostics | Medline Brand        
Segment Reporting [Line Items]        
Net sales 272 239 813 751
Corporate & Other        
Segment Reporting [Line Items]        
Segment adjusted EBITDA (167) (167) (554) (467)
Reconciling Items        
Segment Reporting [Line Items]        
Interest expense, net (118) (213) (373) (646)
Depreciation and amortization (259) (253) (769) (750)
Inventory-related adjustments (122) (2) (154) (38)
Stock-based compensation expense (29) (15) (81) (52)
Litigation gains, net 0 0 0 47
Transaction-related costs (30) (12) (94) (35)
Other non-core charges, net $ (16) $ (19) $ (413) $ (146)